List of works - Judy E. Garber

Counselling framework for moderate-penetrance cancer-susceptibility mutations

scientific article

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

scientific article

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

scientific article

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

scientific article published on 23 October 2017

BRCA1 haploinsufficiency for replication stress suppression in primary cells

scientific article

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

scientific article

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy inBRCA1/2-Associated Stage I/II Breast Cancer

scientific article published on 24 April 2006

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

scientific article

VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy

scientific article

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

scientific article published on 01 May 2001

Evolutionary Pathways in BRCA1-Associated Breast Tumors

scientific article published on April 10, 2012

Rapid progression of prostate cancer in men with a BRCA2 mutation

scientific article published on 24 June 2008

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

scientific article published on January 2016

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

article by Lori J Pierce et al published 1 October 2000 in Journal of Clinical Oncology

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

scientific article published in February 2016

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome

scientific article published on June 2014

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort

scientific article published on 04 March 2012

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014

scientific article published on 01 September 2014

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO

scientific article published on 01 June 2002

Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families

scientific article published on 01 June 2002

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing

scientific article published on 12 September 2016

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer

scientific article

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

scientific article published in July 2004

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

scientific article published on 15 February 2018

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome

scientific article published in January 2006

The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine

scientific article

Complementary and alternative medicine use among women with breast cancer

scientific article published on 01 September 2002

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

scientific article

PALB2 mutations in familial breast and pancreatic cancer

scientific article published on June 2011

Screening for germ line TP53 mutations in breast cancer patients

scientific article published on 01 June 1992

F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome

scientific article

Cancer variation associated with the position of the mutation in the BRCA2 gene

scientific article published in January 2004

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

scientific article published on 13 June 2013

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

scientific article

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

scientific article

Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations

scientific article

Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study

scientific article published in April 2002

Oncologists’ and cancer patients’ views on whole-exome sequencing and incidental findings: results from the CanSeq study

scientific article published on February 11, 2016

Gastric cancer in individuals with Li-Fraumeni syndrome

scientific article published on July 2011

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing

article

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers

scientific article published on July 2009

Familial Gastrointestinal Stromal Tumor Syndrome: Phenotypic and Molecular Features in a Kindred

scientific article published on 01 April 2005

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer

scientific article

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

scientific article published on 30 June 2016

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

scientific article

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

scientific article

Hereditary diffuse gastric cancer: association with lobular breast cancer

scientific article

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

scientific article published on 27 April 2016

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.

scientific article

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

scientific article published on November 2007

List of works by Judy E. Garber

Counselling framework for moderate-penetrance cancer-susceptibility mutations

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

BRCA1 haploinsufficiency for replication stress suppression in primary cells

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy inBRCA1/2-Associated Stage I/II Breast Cancer

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

Evolutionary Pathways in BRCA1-Associated Breast Tumors

Rapid progression of prostate cancer in men with a BRCA2 mutation

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO

Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome

The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine

Complementary and alternative medicine use among women with breast cancer

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

PALB2 mutations in familial breast and pancreatic cancer

Screening for germ line TP53 mutations in breast cancer patients

F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome

Cancer variation associated with the position of the mutation in the BRCA2 gene

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations

Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study

Oncologists’ and cancer patients’ views on whole-exome sequencing and incidental findings: results from the CanSeq study

Gastric cancer in individuals with Li-Fraumeni syndrome

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers

Familial Gastrointestinal Stromal Tumor Syndrome: Phenotypic and Molecular Features in a Kindred

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Hereditary diffuse gastric cancer: association with lobular breast cancer

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?